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was noted in 16 pateints (20 %). Incidence of types of arteritis Type
I- 04%; Type II- 05% , Type III -66%; Type IV - 21%; Type V- 04% .
Vessels involved were aortic arch (53%), renal artery (38%), sub-
clavian artery (18 %), descending aorta (22%), carotid (15%), coro-
nary (15%) and pulmonary artery (4%). 40 patents (50%) were on
antihypertensive therapy, out of which 5 cases needed renal ar-
tery stenting. 24 patients were on steroid maintanence therapy,
which helped in lowering of ESR. 5 patients were on both meth-
otrexate and steroid.
Conclusions: Aortoarteritis is a rare disease, more commonly seen
in young females in second and third decade. Type III involvement
was more common. Most patients require repeated and at times,
prolonged course of therapy. Although mortality was low, sub-
stantial morbidity occurred in most patients.
Study of clinical presentation in patients with
LMCA disease
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Narayana Medical College, Nellore, India
Background: Left main coronary artery disease is considered a
dreaded entity among CAD. Clinical presentation of LMCA pre-
sents atypically in comparison to other coronary artery stenosis.
Objective: To study the clinical presentation of patients with
LMCA disease vs. non LMCA disease in patients with CAD.
Methods: 508 patients admitted to department of cardiology with
CAD between Jan 2013 and December 2013 who underwent CAG
were analysed retrospectively. Patients were divided into 2 groups
with and without LMCA.
Results: Among 508 patients who underwent CAG 102 patients
had significant LMCA disease, 406 patients without LMCA disease.
Atypical Chest pain (mid scapular pain with radiation to front of
chest) with/without dyspnoea was more prevalent in patients
with LMCA disease. Atypical chest pain with dyspnoea was pre-
sent in 37pt in LMCA vs. 18 pt in non-LMCA (34.5% vs. 4.43%,
p<0.001) while atypical chest pain was present in 42 pt with LMCA
vs. 53 pt in non LMCA group (41.17% vs. 13.05%,p<0.001) while
typical angina was present in 23pt in LM disease vs. 335pt with
non-LMCA pt (22.5% vs. 82.5% , p<0.046).
Conclusion: This study concludes that atypical chest pain espe-
cially midscapular pain with radiation to front of chest if associ-
ated dyspnoea strongly predicts for LMCAover non- LMCAdisease.
Cardiac manifestations in HIV
Kavya
Osmania General Hospital, India
Background: Cardiac manifestations in HIV are varied and only a
few studies are available from India.
Methods: 100 HIV e infected patients attending the Osmania
general hospital were included in this prospective study irre-
spective of their duration of their illness and ART status.Patients
with evidence of heart disease previous to the diagnosis of their
HIV infection were specifically excluded.
Results: Among100 patients 82% are males and 18% are fema-
les.were staged according toWHO clinical staging of HIV/AIDS. 6%
belong to stage 2, 50% belong to stage 3 and 44% belong to stage 4.
incidence of cardiacmanifestations is 22% among the HIVpatients
in males is 23.17% it is 16.66% in females. most common is dilated
cardiomyopathy 22.72%, pericardial effusion 18.18%,coronary ar-
tery disease 13.63%,pulmonary hypertension 13.63%, left ventric-
ular hypertrophy 9.09%,diastolic dysfunction 4.54%, mitral valve
prolapsed 4.54%, other valvular heart disease 4.54%, pulmonary
thromboembolism 4.54% and mediastinal mass 4.54%.Comparing
various stages of HIV, in stage 2 one patient has mitral valve
prolapse. In Stage 3 the incidence is 18% and the incidence in stage
4 is 27.27%. The incidence of dilated cardiomyopathy and peri-
cardial effusion is higher in stage 4. The incidence is 100% and 75%
respectively. The incidence of pulmonary hypertension, coronary
artery disease, left ventricular hypertrophy and diastolic
dysfunction is found to be more in stage 3. The incidences are
66.67% for each of these conditions. Almost 86.37% of manifes-
tations occur when CD4 count is below 250. 78.95% of males
consume alcohol and 84.21% of males smoke. Dyslipidemia is
seen in 22.73% with cardiac disease and inpatients without car-
diac diseases 2.56%. Systemic HTNis seen in 22.72% in patients
with cardiac disease and in patients without cardiac disease is
2.56%. DM in 18.18% in patients with cardiac disease and in pa-
tients without cardiac disease is 1.28%.
Conclusions: Cardiovascular complications are commonly seen in
HIV-infected patients. The presence of risk factors like systemic
HTN and DM increases the risk of cardiac diseases.
Study of cardiovascular manifestations in HIV
infected adult patients
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Background: India is estimated to have 2.4 million HIV-infected
individuals. HIV affects all systems of body, cardiac abnormalities
being less well documented.
Aims: Study prevalence of cardiac diseases in HIV/AIDS pts, the
types of cardiac diseases and comparison of the prevalence and
type of cardiac diseases between pts who had treatment and who
had not.
Methods: Two hundred consecutive HIVpositive pts were inclu-
de.Detailed clinical-profile, examination, routine investigations,
ECG and ECHO etc were done, angiograms not done due to cost
issues.
Results: 86% of pts were between 15-49yrs, only 14%>50. 65%were
males, 35% females. 64% patients had CD4 count <200, 25% pa-
tients 201-350 and 11% had more than 350. 45% patients were on
ART and 55% pts were not on ART. 67 pts had AIDS and 33 pts did
not have AIDS. Cardiac disorders were detected in 44%, 56% pts
had no cardiac disorders. Cardiac symptoms were present in only
5% of pts. 6% pericardial effusion, 5% systolic dysfunction, 5%
pulmonary hypertension, 4% dilated cardiomyopathy, 1% mitral
regurgitation. 80% had normal ECG, sinus tachycardia 15%, low-
voltage-complexes 5%. 75% normal chest X-ray, cardiomegaly in
6%. 50% had cavity/infiltrates, 16% pleural effusion, 26% pneu-
monia, 5% bilateral extensive reticulonodular shadows. Low Hb
level was significantly associated with cardiac disorder. Symp-
tomatic cardiac disease was present in patients-with-AIDS (CD4
<200). Pts with cardiac disorders had significantly low CD4 count
as compared to the pts without. Lower CD4 count significantly
associated with pericardial effusion. Two patients on ART had
cardiomyopathy and as against four patients who were not on
ART.
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Conclusion: Prevalence of cardiac involvement was 44%. Only
5% symptomatic. Mean CD4 lower in patients with cardiac disor-
der than those without. Lower CD4 count significantly associated
with pericardial effusion. 45% of the patients were receiving
ART and 55% were not. Noninvasive investigations like echocar-
diography helps in early diagnosis of asymptomatic cardiac dis-
orders. Cardiac disorders in HIV infected patients and only small
percentage of the patients with cardiac disorders are symptom-
atic.
Pacing & Electrophysiology
Effect of vacuum suction drainage system
placement on clinical outcomes during routine
permanent pacemaker implantation
Chetan Sharma, Chhabindra Prasad Tripathi, Madhavi Anand,
Azhar Zawed, R.K. Pandey, Naveen Bisht, Harish Mandal
Bharat Heart Institute, Dehradun, India
Background: Achieving adequate hemostasis in blind pacemaker
pocket is difficult. Pacemaker site hematoma with its attendant
complications is a frequent occurrence (17-25%) after permanent
pacemaker Implantation(PPI) especially in patients of ischemic
and valvular heart disease on anticoagulation and antiplatelet
therapy.
Methods: 84 patients requiring PPI were included in present study.
61 (72%) Patients were male, 23 (27%) patients were females. Clin-
ical presentation was syncope in 35 (41%) patients, complete heart
block in 46 (54%), Symptomatic sinus & Junctional Bradycardia in
10 cases (5%). 27 (32%) patients had coronary artery disease and
were on dual antiplatelets therapy with Ecosprin and Clopidogrel
/Prasugrel. Two ( 2.4%) patients of rheumatic heart diseasewere on
Acitrom. 89% patient received single chamber and 11% patient
received dual chamber pacemakers. Permanent Pacemaker was
implanted in routine manner in right infraclavicular fossa. As a
part of protocol MINI VAC closed wound suction drainage system
was placed into pacemaker pocket through separate dependent
portion of pacemaker site. Injection Targocid , Piptazwere used for
two days in therapeutic dosage as per hospital protocol. Patients
were discharged after 48 hours after removal of vacuum suction
drainage system and wound dressing. Patients were followed for
period of three months on regular basis.
Results: There was no incidence of pacemaker site hematoma,
local pain or tenderness, infection during hospital stay in all 84
patients. Neither these end points were observed during follow
period of three months.
Conclusion: Permanent pacemaker hematoma can be avoided
with routine use of vacuum suction drainage system placement
during permanent pacemaker implantation. There is no risk of
pacemaker pocket infection requiring repeated hospital admis-
sions and risk of explantation.
3D CARTO guided VT ablation in post MI patients
e A single centre experience
Sandeep Goel, Daljeet Saggu, Sachin Yalagudri, Abhijeet Shelke,
C.S. Sridevi, C. Narasimhan
Care Hospital, Hyderabad, India
Background: Radiofrequency ablation (RFA) for VT is an estab-
lished therapy in patients with ICD to reduce the number of
shocks. As many of our patients could not afford ICD, we offered
RFA as a primary therapy to these patients. We present our
experience of RF VT ablation in Indian population.
Methods: Patients who underwent RFA for VT ablation in our
centre from January 2008 toMay 2013 formed the study group.
Patients were categorized as Group I (with ICD) and Group II
(without ICD). Time-to-event analysis was performed. The pri-
mary end-points studied were VT recurrence and all-cause
mortality.
Results: Of 48 patients who underwent procedure,17 were in
Group I and 31 in Group II.
Median time-interval between ICD implantation and RFA in
Group I was 3yrs (Range: 1-12years). One hundred thirty nine
morphologically distinct ventricular tachycardias were induced in
the lab with an average of 2.6 VTs per patient. Hemodynamically
unstable or nonsustained VTs were 55% and hemodynamically
stable and sustained were 45%. Freedom from recurrence of VT
was observed in 77%with complete procedural success and 53% of
patients with partial success or procedure failure (p ¼ 0.22). The
freedom from recurrent VTs was 45% (N¼9) in Group I and 86%
(N¼3) in Group II (p¼0.0034) (Fig.1). Two patients had procedure
failure. All cause mortality was 4% (N¼2). There were no
arrhythmic deaths.
Conclusion: VT ablation is a safe procedure and can be considered
as a primary therapy in patients who cannot afford an ICD. In
patients with ICD, early preventive VT ablation at the time of ICD
implantation may be better than later curative therapy for
recurrent shocks.
The Indian Society of Electrocardiology and the
Indian Heart Rhythm Society device survey
S. Jayprakash, Shomu Bohra, Vinay Jetley, Amit Vora,
Yash Lokhandwala, Ajay Naik, C. Narsimhan, S.B. Gupta
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Background: There is no data on indications, clinical character-
istics of patients and type of cardiac implantable electrical devices
(CIED), including pacemakers, intracardiac defibrillators (ICD) and
cardiac resynchronization therapy (CRT) in India.
Aim: The CIED survey was conducted to document the type of
devices used, indications and capture demographic characteris-
tics, clinical status and co-morbidities of patients undergoing
these implants in India.
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